Literature DB >> 34087613

Does COVID 19 generate a milieu for propagation of mucormycosis?

Deepak Pandiar1, N Siva Kumar2, Rahul Anand3, Mala Kamboj2, Anjali Narwal2, P M Shameena4.   

Abstract

Corona Virus Disease 2019 (COVID 2019), caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), is a dreadful infectious disease which has emerged as one of the most significant medical emergency affecting everyone directly or indirectly. COVID 2019 is a multisystem disease and causes severe immunosuppression. Initially thought to affect mainly the respiratory system, it strikes all vital organ systems and cause defects in cardio-circulatory, respiratory system and gastrointestinal systems to name a few leading to copious biochemical alterations. Reports show there is thromoembolism, raised ferritin levels, lymphocytopenia, thrombocytopenia, lactic acidosis, acute diabetes like state and cytokine storm. Data regarding levels of neutrophils is equivocal. Further there is increased incidence regarding high incidents of mucormycosis in COVID 2019 positive subjects. In the present paper, we identified and correlated the virus mediated biochemical alterations as the potential ideal environment for propagation of mucorales; and thus concentrate on early diagnosis and treatment of mucormycosis in COVID 2019 cases.
Copyright © 2021 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  ACE2; COVID 2019; Mucorales; Mucormycosis; SARS-CoV-2

Year:  2021        PMID: 34087613     DOI: 10.1016/j.mehy.2021.110613

Source DB:  PubMed          Journal:  Med Hypotheses        ISSN: 0306-9877            Impact factor:   1.538


  9 in total

1.  Histopathological analysis of soft tissue changes in gingival biopsied specimen from patients with underlying corona virus disease associated mucormycosis (CAM).

Authors:  D Pandiar; P Ramani; R-P Krishnan; D Y
Journal:  Med Oral Patol Oral Cir Bucal       Date:  2022-05-01

Review 2.  Current Treatment Options for COVID-19 Associated Mucormycosis: Present Status and Future Perspectives.

Authors:  Yasasve Madhavan; Kadambari Vijay Sai; Dilip Kumar Shanmugam; Aashabharathi Manimaran; Karthigadevi Guruviah; Yugal Kishore Mohanta; Divyambika Catakapatri Venugopal; Tapan Kumar Mohanta; Nanaocha Sharma; Saravanan Muthupandian
Journal:  J Clin Med       Date:  2022-06-23       Impact factor: 4.964

3.  Oral Tissue Involvement and Probable Factors in Post-COVID-19 Mucormycosis Patients: A Cross-Sectional Study.

Authors:  Neelam Chandwani; Sandeep Dabhekar; Kalai Selvi; Roshan Noor Mohamed; Shahabe Saquib Abullais; Muhamood Moothedath; Ganesh Jadhav; Jaya Chandwani; Mohmed Isaqali Karobari; Ajinkya M Pawar
Journal:  Healthcare (Basel)       Date:  2022-05-13

4.  Characteristics and Outcomes of a Series of COVID-Associated Mucormycosis Patients in Two Different Settings in Egypt Through the Third Pandemic Wave.

Authors:  Yousef A Fouad; Hatem M Bakre; Mahmoud A Nassar; Mohamed Omar A Gad; Ashraf Abdelsalam Kandeel Shaat
Journal:  Clin Ophthalmol       Date:  2021-12-22

Review 5.  COVID19 associated mucormycosis: A review.

Authors:  Priyadharsini R Palanisamy; Dhivya Elango
Journal:  J Family Med Prim Care       Date:  2022-02-16

Review 6.  COVID-19 and Plethora of Fungal Infections.

Authors:  Reetu Kundu; Nidhi Singla
Journal:  Curr Fungal Infect Rep       Date:  2022-04-09

7.  Chronic Invasive Aspergillosis with Fulminant Mucormycosis Sparing Palate in a Post-COVID-19 Patient - A Case Report.

Authors:  Pratibha Ramani; Reshma Poothakulath Krishnan; Deepak Pandiar; J Georgia Benitha; Karthikeyan Ramalingam; S Gheena
Journal:  Ann Maxillofac Surg       Date:  2022-08-16

Review 8.  Mucormycosis Amid COVID-19 Crisis: Pathogenesis, Diagnosis, and Novel Treatment Strategies to Combat the Spread.

Authors:  Shreya Dogra; Akanksha Arora; Aashni Aggarwal; Gautam Passi; Akanksha Sharma; Gurpal Singh; Ravi P Barnwal
Journal:  Front Microbiol       Date:  2022-01-04       Impact factor: 5.640

Review 9.  New insights on mucormycosis and its association with the COVID-19 pandemic.

Authors:  Mona G Alshahawey; Ghadir S El-Housseiny; Noha S Elsayed; Mohammad Y Alshahrani; Lamia Mel Wakeel; Khaled M Aboshanab
Journal:  Future Sci OA       Date:  2021-12-16
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.